Physician
Sanford Medical Center
Sanford Medical Center was paid $69.06M by Medicaid between Jan 2018 and Dec 2024, across 429 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.
33Billing provider infoSANFORD MEDICAL CENTER
SIOUX FALLS, SD 57105
SIOUX FALLS, SD 57105
33aNPI1093090342assigned 10/19/2011
33bProvider typeSurgery Physician
28Total paid$69.06M
24GClaims1,516,888
24DCodes billed429
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgery Physician providers in South Dakota
Rank by total paid#1 of 10
Median peer was paid$6K
This provider vs. median11,277×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MORRISON, TONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 127,796 | $4.88M | |
| 2019 | 140,672 | $5.69M | |
| 2020 | 125,058 | $5.85M | |
| 2021 | 229,362 | $10.72M | |
| 2022 | 262,679 | $11.59M | |
| 2023 | 319,538 | $14.08M | |
| 2024incomplete | 311,783 | $16.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 275,528 | 218,857 | $10.57M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 136,969 | 114,351 | $7.18M |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 4.7% | 2,396 | 2,161 | $3.23M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.8% | 23,046 | 19,765 | $2.61M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.8% | 24,839 | 21,032 | $1.92M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.7% | 23,178 | 20,407 | $1.88M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.7% | 47,891 | 11,469 | $1.86M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.4% | 20,348 | 17,612 | $1.66M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.4% | 29,941 | 25,797 | $1.65M |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 2.3% | 3,982 | 562 | $1.61M |
| 99480 | Subsequent intensive care, per day, low birth weight infant | 2.2% | 8,344 | 1,243 | $1.53M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 21,665 | 19,446 | $1.43M |
417 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.8% | 18,899 | $1.27M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.7% | 32,367 | $1.19M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.5% | 7,029 | $1.03M |
| 90837 | Psychotherapy session, about an hour | 1.4% | 12,636 | $999K |
| W0037 | 1.4% | 67,860 | $975K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 14,076 | $960K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.2% | 11,899 | $823K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.2% | 14,414 | $810K |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | 1.1% | 1,815 | $726K |
| 99205 | Prolong outpt/office vis | <1% | 6,176 | $643K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 17,686 | $630K |
| 59510 | <1% | 421 | $627K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 9,077 | $621K |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 4,229 | $584K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 11,141 | $544K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 9,886 | $529K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 12,514 | $528K |
| 99283 | Emergency room visit (moderate) | <1% | 9,354 | $500K |
| 99254 | <1% | 3,678 | $481K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 5,026 | $481K |
| 99223 | Prolong inpt eval add15 m | <1% | 4,751 | $415K |
| 99468 | <1% | 515 | $396K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,481 | $382K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 425 | $356K |
| 99417 | Prolong home eval add 15m | <1% | 5,543 | $356K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34,036 | $346K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 1,431 | $328K |
| 99460 | <1% | 4,058 | $324K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 5,670 | $299K |
| 01922 | <1% | 1,426 | $296K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,733 | $296K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 3,659 | $290K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 5,211 | $290K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 7,134 | $280K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,965 | $280K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 2,286 | $280K |
| 54150 | <1% | 2,002 | $269K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 10,473 | $255K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 6,395 | $248K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 8,977 | $235K |
| 00731 | <1% | 2,490 | $231K | |
| 00840 | <1% | 1,087 | $231K | |
| 59025 | Fetal non-stress test | <1% | 10,653 | $228K |
| 99255 | <1% | 1,288 | $217K | |
| 17110 | <1% | 3,188 | $213K | |
| 90651 | <1% | 8,472 | $210K | |
| 01961 | <1% | 954 | $206K | |
| 99188 | <1% | 8,307 | $199K | |
| 00790 | <1% | 936 | $196K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 32,602 | $188K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 2,197 | $179K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 839 | $172K |
| 90671 | <1% | 6,157 | $162K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 2,237 | $159K |
| 99221 | <1% | 3,373 | $159K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 1,452 | $156K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 10,342 | $154K |
| 76830 | Ultrasound, transvaginal | <1% | 3,701 | $136K |
| 99253 | <1% | 1,453 | $135K | |
| 43762 | <1% | 758 | $131K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,586 | $127K |
| 90715 | <1% | 7,591 | $121K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,072 | $118K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,970 | $114K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,875 | $100K |
| 99477 | <1% | 306 | $97K | |
| 76825 | <1% | 1,399 | $95K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,743 | $92K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 98 | $91K |
| 92567 | <1% | 5,950 | $89K | |
| 93970 | <1% | 2,486 | $88K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,291 | $86K |
| 99243 | <1% | 995 | $84K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,594 | $83K |
| 99383 | <1% | 1,002 | $83K | |
| 90961 | <1% | 1,014 | $82K | |
| 91320 | <1% | 1,094 | $80K | |
| 00813 | <1% | 751 | $78K | |
| 90686 | <1% | 25,586 | $77K | |
| 93325 | <1% | 5,083 | $76K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 2,312 | $75K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 693 | $75K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 956 | $73K |
| 76801 | <1% | 1,295 | $71K | |
| 11981 | <1% | 803 | $71K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 286 | $70K |
| 12001 | <1% | 859 | $70K | |
| 99462 | <1% | 2,064 | $70K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,789 | $70K |
| 90739 | <1% | 506 | $70K | |
| 76813 | <1% | 1,331 | $68K | |
| 73630 | <1% | 4,842 | $68K | |
| 58300 | <1% | 680 | $67K | |
| 20610 | <1% | 2,001 | $67K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,504 | $66K |
| 94010 | <1% | 5,147 | $65K | |
| 0001A | <1% | 2,372 | $62K | |
| 99464 | <1% | 1,059 | $62K | |
| 76820 | <1% | 3,134 | $61K | |
| 93971 | <1% | 1,850 | $61K | |
| 00126 | <1% | 618 | $61K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,551 | $61K |
| 92587 | <1% | 3,234 | $60K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,389 | $59K |
| 99381 | <1% | 648 | $59K | |
| 99152 | <1% | 3,400 | $58K | |
| 59514 | <1% | 137 | $58K | |
| 95720 | <1% | 357 | $58K | |
| 94060 | <1% | 3,193 | $57K | |
| 00300 | <1% | 421 | $57K | |
| 0002A | <1% | 1,645 | $56K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,734 | $55K |
| 76642 | <1% | 1,582 | $55K | |
| 73610 | <1% | 4,024 | $54K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 569 | $54K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 305 | $53K |
| 76827 | <1% | 1,314 | $52K | |
| 73110 | <1% | 3,740 | $49K | |
| 99384 | <1% | 570 | $49K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 114 | $48K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 191 | $48K |
| 74018 | <1% | 3,275 | $46K | |
| 93226 | <1% | 1,243 | $45K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,153 | $44K |
| 90480 | <1% | 1,930 | $41K | |
| 90621 | <1% | 2,976 | $40K | |
| 00400 | <1% | 337 | $38K | |
| 0071A | <1% | 1,046 | $38K | |
| 59410 | <1% | 41 | $38K | |
| 00811 | <1% | 542 | $37K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,501 | $36K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,535 | $36K |
| 99382 | <1% | 452 | $36K | |
| 12011 | <1% | 368 | $35K | |
| 99173 | <1% | 2,860 | $35K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 985 | $35K |
| 93304 | <1% | 750 | $34K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 617 | $34K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 1,583 | $34K |
| 92551 | <1% | 2,602 | $32K | |
| 93308 | <1% | 1,337 | $32K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 568 | $32K |
| 73130 | <1% | 2,462 | $32K | |
| 94729 | <1% | 1,868 | $31K | |
| 95886 | <1% | 512 | $31K | |
| 95251 | <1% | 1,479 | $30K | |
| 93227 | <1% | 2,152 | $29K | |
| 90678 | <1% | 243 | $29K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,165 | $29K |
| 73560 | <1% | 2,177 | $28K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 743 | $28K |
| 0072A | <1% | 725 | $27K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 749 | $27K |
| 99219 | <1% | 329 | $26K | |
| 73562 | <1% | 1,765 | $26K | |
| 36620 | <1% | 596 | $25K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,291 | $25K |
| 0124A | <1% | 834 | $24K | |
| 73030 | <1% | 1,772 | $24K | |
| 93925 | <1% | 874 | $23K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,348 | $23K |
| 90619 | <1% | 2,762 | $22K | |
| 73140 | <1% | 2,140 | $22K | |
| 90670 | <1% | 10,593 | $21K | |
| 96137 | <1% | 332 | $21K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,011 | $21K |
| 95816 | <1% | 268 | $21K | |
| 92552 | <1% | 1,144 | $21K | |
| 73080 | <1% | 1,421 | $20K | |
| 11721 | <1% | 1,173 | $20K | |
| 93016 | <1% | 1,795 | $20K | |
| 99217 | <1% | 393 | $19K | |
| 93295 | <1% | 847 | $19K | |
| 94726 | <1% | 1,092 | $19K | |
| 64615 | <1% | 277 | $19K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,503 | $19K |
| 92555 | <1% | 1,401 | $19K | |
| 93922 | <1% | 1,509 | $18K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 323 | $18K |
| 93225 | <1% | 940 | $18K | |
| 31575 | <1% | 277 | $18K | |
| 93321 | <1% | 2,201 | $18K | |
| 0054A | <1% | 552 | $18K | |
| 92015 | Determination of refractive state | <1% | 1,955 | $18K |
| 99177 | <1% | 3,226 | $17K | |
| 93320 | <1% | 962 | $17K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 184 | $17K |
| 74019 | <1% | 1,087 | $16K | |
| 99421 | <1% | 1,669 | $16K | |
| 43235 | <1% | 93 | $16K | |
| 93294 | <1% | 1,392 | $16K | |
| 93018 | <1% | 1,931 | $16K | |
| 77066 | Tomosynthesis, mammo | <1% | 365 | $15K |
| 90656 | <1% | 3,685 | $15K | |
| 96133 | <1% | 110 | $15K | |
| 92134 | <1% | 881 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,225 | $14K |
| 99418 | Prolong nursin fac eval 15m | <1% | 194 | $14K |
| 95811 | <1% | 83 | $14K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 334 | $13K |
| 90732 | <1% | 240 | $13K | |
| 99252 | <1% | 174 | $13K | |
| 95117 | <1% | 1,323 | $12K | |
| 10061 | <1% | 84 | $12K | |
| 77062 | <1% | 86 | $12K | |
| 96132 | <1% | 248 | $12K | |
| 0081A | <1% | 399 | $11K | |
| 72100 | <1% | 607 | $11K | |
| 73502 | <1% | 662 | $11K | |
| 99471 | <1% | 16 | $11K | |
| 69210 | <1% | 409 | $11K | |
| 31500 | <1% | 119 | $11K | |
| 01480 | <1% | 88 | $11K | |
| 95819 | <1% | 141 | $11K | |
| 73590 | <1% | 743 | $11K | |
| 99385 | <1% | 122 | $11K | |
| 93000 | <1% | 785 | $10K | |
| 99459 | <1% | 627 | $10K | |
| 81025 | <1% | 1,675 | $10K | |
| 90380 | <1% | 322 | $10K | |
| 90620 | <1% | 281 | $10K | |
| 0004A | <1% | 372 | $10K | |
| 90474 | <1% | 987 | $10K | |
| 72170 | <1% | 795 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,127 | $10K |
| 69209 | <1% | 760 | $10K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,519 | $9K |
| 76821 | <1% | 257 | $9K | |
| 0500F | <1% | 1,086 | $9K | |
| 0051A | <1% | 264 | $9K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,321 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 130 | $9K |
| 0052A | <1% | 241 | $9K | |
| 93880 | <1% | 279 | $9K | |
| 10060 | <1% | 137 | $9K | |
| 92002 | <1% | 138 | $8K | |
| 90750 | <1% | 64 | $8K | |
| 94664 | <1% | 736 | $8K | |
| 73090 | <1% | 608 | $8K | |
| 90381 | <1% | 444 | $8K | |
| 96381 | <1% | 757 | $8K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 230 | $8K |
| 97803 | <1% | 317 | $7K | |
| 00920 | <1% | 62 | $7K | |
| 0154A | <1% | 242 | $7K | |
| 92557 | <1% | 188 | $7K | |
| 80050 | General health panel | <1% | 186 | $7K |
| 96136 | <1% | 351 | $7K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 251 | $7K |
| 96161 | <1% | 748 | $7K | |
| 73564 | <1% | 389 | $7K | |
| 96127 | <1% | 827 | $6K | |
| 77065 | Tomosynthesis, mammo | <1% | 168 | $6K |
| 76818 | <1% | 138 | $6K | |
| V5266 | Battery for use in hearing device | <1% | 576 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 310 | $6K |
| 0074A | <1% | 154 | $6K | |
| 93926 | <1% | 310 | $6K | |
| 0082A | <1% | 177 | $6K | |
| 84439 | <1% | 1,088 | $5K | |
| 42830 | <1% | 34 | $5K | |
| 98967 | <1% | 240 | $5K | |
| 20611 | <1% | 79 | $4K | |
| 97802 | <1% | 124 | $4K | |
| 93458 | <1% | 25 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 225 | $4K |
| 99242 | <1% | 63 | $4K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 16 | $4K |
| 90716 | <1% | 4,335 | $4K | |
| 80061 | Lipid panel | <1% | 471 | $4K |
| 11982 | <1% | 38 | $4K | |
| 31622 | <1% | 16 | $4K | |
| 96380 | <1% | 312 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 911 | $3K |
| 90710 | <1% | 4,104 | $3K | |
| 96409 | <1% | 33 | $3K | |
| G9151 | Mapcp demonstration - state provided services | <1% | 18 | $3K |
| 93296 | <1% | 172 | $3K | |
| 90707 | <1% | 4,301 | $3K | |
| 90734 | <1% | 3,134 | $3K | |
| 0173A | <1% | 102 | $3K | |
| 98968 | <1% | 144 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 144 | $3K |
| 73552 | <1% | 165 | $3K | |
| 81003 | <1% | 1,638 | $3K | |
| 76937 | <1% | 304 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 56 | $3K |
| 93454 | <1% | 18 | $3K | |
| 92652 | <1% | 90 | $3K | |
| 12002 | <1% | 26 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 65 | $2K |
| 93271 | <1% | 20 | $2K | |
| 92553 | <1% | 77 | $2K | |
| 0121A | <1% | 82 | $2K | |
| 91319 | <1% | 437 | $2K | |
| 99235 | <1% | 14 | $2K | |
| 99245 | <1% | 13 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 88 | $2K |
| 64721 | <1% | 14 | $2K | |
| 36416 | <1% | 3,089 | $2K | |
| 90633 | <1% | 9,332 | $2K | |
| 81001 | <1% | 1,095 | $2K | |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 20 | $2K |
| 99225 | <1% | 32 | $2K | |
| 11055 | <1% | 73 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 366 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 252 | $2K |
| 72040 | <1% | 74 | $2K | |
| 91318 | <1% | 383 | $1K | |
| 99422 | <1% | 46 | $1K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 37 | $1K |
| 92579 | <1% | 42 | $1K | |
| 58301 | <1% | 25 | $1K | |
| 85027 | <1% | 346 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,096 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 41 | $1K |
| 98966 | <1% | 109 | $1K | |
| 92585 | <1% | 15 | $1K | |
| 99466 | <1% | 12 | $1K | |
| 11056 | <1% | 85 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 66 | $1K |
| 87210 | <1% | 366 | $1K | |
| 90473 | <1% | 111 | $1K | |
| 78431 | <1% | 18 | $1K | |
| 82728 | <1% | 131 | $983.99 | |
| 00910 | <1% | 15 | $949.41 | |
| 29065 | <1% | 20 | $922.66 | |
| 90685 | <1% | 389 | $922.22 | |
| 93298 | <1% | 28 | $902.42 | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 12 | $887.77 |
| 93272 | <1% | 64 | $873.60 | |
| 0083A | <1% | 26 | $857.82 | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 19 | $850.00 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 32 | $826.40 |
| 99442 | <1% | 161 | $795.31 | |
| 90696 | <1% | 3,910 | $710.39 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 103 | $648.98 |
| 83550 | <1% | 124 | $638.06 | |
| 76536 | <1% | 14 | $599.54 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 34 | $597.92 |
| 83540 | <1% | 144 | $564.07 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 232 | $561.10 |
| 0151A | <1% | 14 | $553.48 | |
| 73070 | <1% | 46 | $543.24 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13 | $532.37 |
| 93248 | <1% | 43 | $522.34 | |
| 0003A | <1% | 21 | $511.74 | |
| 86803 | <1% | 52 | $488.03 | |
| 92083 | <1% | 21 | $472.71 | |
| 0011A | <1% | 35 | $472.04 | |
| 87077 | <1% | 88 | $467.98 | |
| 29125 | <1% | 17 | $438.73 | |
| 73660 | <1% | 31 | $404.43 | |
| 77077 | <1% | 17 | $371.11 | |
| 76857 | <1% | 22 | $364.70 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 2,949 | $355.22 |
| 71045 | Radiologic examination, chest; single view | <1% | 27 | $351.74 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 14 | $350.90 |
| 99292 | <1% | 25 | $332.03 | |
| 78434 | <1% | 17 | $329.42 | |
| 99443 | <1% | 42 | $312.84 | |
| 92550 | <1% | 18 | $312.30 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 21 | $311.19 |
| 92556 | <1% | 15 | $309.54 | |
| 17340 | <1% | 13 | $261.97 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 15 | $253.00 |
| 85018 | <1% | 136 | $239.74 | |
| 99441 | <1% | 86 | $236.65 | |
| 36410 | <1% | 16 | $226.25 | |
| 82570 | <1% | 76 | $215.42 | |
| 86780 | <1% | 21 | $214.48 | |
| 87340 | <1% | 38 | $199.87 | |
| 93244 | <1% | 14 | $186.66 | |
| 84702 | <1% | 24 | $165.50 | |
| 86140 | <1% | 47 | $163.14 | |
| 73600 | <1% | 20 | $158.54 | |
| 90672 | <1% | 169 | $145.56 | |
| 96116 | <1% | 25 | $131.20 | |
| 80076 | <1% | 21 | $114.38 | |
| 90717 | <1% | 23 | $113.84 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 49 | $107.82 |
| 87186 | <1% | 16 | $97.30 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 352 | $90.43 |
| 83735 | <1% | 20 | $88.44 | |
| 83690 | <1% | 13 | $82.68 | |
| 86762 | <1% | 12 | $79.13 | |
| 83516 | <1% | 20 | $74.42 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 14 | $67.50 |
| 82565 | <1% | 19 | $52.22 | |
| 84156 | <1% | 18 | $38.70 | |
| 82043 | <1% | 15 | $35.84 | |
| 90660 | <1% | 53 | $34.21 | |
| 99406 | <1% | 14 | $27.22 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 18 | $20.14 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 32 | $16.42 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 93 | $15.39 |
| 90674 | <1% | 264 | $14.00 | |
| 90785 | <1% | 379 | $8.40 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 44 | $0.00 |
| 91300 | 0% | 4,886 | $0.00 | |
| 90461 | 0% | 12,934 | $0.00 | |
| 90700 | 0% | 287 | $0.00 | |
| 91308 | 0% | 656 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 25 | $0.00 |
| 91312 | 0% | 886 | $0.00 | |
| 90713 | 0% | 13 | $0.00 | |
| 90648 | 0% | 28 | $0.00 | |
| 90680 | 0% | 10,615 | $0.00 | |
| 91315 | 0% | 276 | $0.00 | |
| 90744 | 0% | 5,567 | $0.00 | |
| 90698 | 0% | 10,975 | $0.00 | |
| 90697 | 0% | 4,926 | $0.00 | |
| 91305 | 0% | 1,328 | $0.00 | |
| 91307 | 0% | 2,113 | $0.00 | |
| 91317 | 0% | 160 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| 91301 | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORRISON, TONY (VICE PRESIDENT, REVENUE CYCLE)
Parent organizationSANFORD MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | $50.18M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $47.45M |
| Sanford Bismarck | Bismarck, ND | $43.96M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $27.11M |
| Sanford Medical Center | Sioux Falls, SD | $24.40M |
| FM Ambulance Service, INC | Fargo, ND | $23.80M |
| Sanford Medical Center | Sioux Falls, SD | $18.03M |
| Sanford Health Network | Worthington, MN | $7.58M |
| Sanford Clinic | Sioux Falls, SD | $6.04M |
| Sanford Clinic | Sioux Falls, SD | $5.45M |
| Sanford Healthcare Accessories, LLC | Fargo, ND | $4.79M |
| Sanford Health Network North | Thief River Falls, MN | $3.28M |
| Sanford Clinic | Sioux Falls, SD | $2.96M |
| Sanford Health Network | Jackson, MN | $2.81M |
| Sanford Clinic | Watertown, SD | $2.02M |
| Black Hills Orthopedic & Spine Center, INC. | Rapid City, SD | $1.71M |
| Sanford Health Network | Chamberlain, SD | $1.47M |
| Sanford Health Network | Vermillion, SD | $1.31M |
| Sanford Health Network | Luverne, MN | $1.27M |
| Sanford Medical Center Fargo | Pelican Rapids, MN | $1.01M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.